JPRN-UMIN000011710已完成未知
ew Chiba Refractory Schizophrenia Treatment (CREST)-LAI study: Effectiveness of Risperidone Long-acting Injectable for Treatment-resistant Schizophrenia - J-CREST study
Department of Psychiatry, Graduate School of Medicine, Chiba University0 个研究点目标入组 50 人开始时间: 2013年9月20日最近更新:
适应症
试验速览
- 阶段
- 未知
- 状态
- 已完成
- 发起方
- 入组人数
- 50
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
- 年龄范围
- ot applicable 至 ot applicable（—）
- 性别
- All
入选标准
- 未提供
排除标准
- •A)with a treatment history of RLAI injection B)under treatment with clozapine C)under ECT treatment D)with any other Axis 1 or 2 psychiatric disorder E)with clinically severe physical disease F)with pregnancy or suspected pregnancy G)a physician assessed the patient as unsuitable for participation in the study.
研究者
相似试验
终止
3 期
Augmentation of antipsychotic medication with anticonvulsant in the management of treatment resistant schizophreniaMental and Behavioural DisordersSchizophreniaISRCTN77257074King's College London371
已完成
不适用
Pilot study for a new treatment of schizophrenia: a double-blind crossover transcranial magnetic stimulatioSchizophreniaISRCTN93378085Record Provided by the NHSTCT Register - 2007 Update - Department of Health12
进行中（未招募）
1 期
Immunological treatment for SchizophreniaTreatment-resistant patients with schizophrenia spectrum disorder (SSD)EUCTR2018-004618-17-SERegion Örebro län12
终止
1 期
Sodium benzoate in chronic schizophrenia – an open label, add-on safety and efficacy studyTreatment ResistanceMental Health - SchizophreniaSchizophreniaACTRN12615000460505niveristy of Otago1
招募中
不适用
Transforming treatments for schizophrenia: Virtual reality, brain stimulation and social cognition.schizoaffective disordersocial cognitionMental Health - SchizophreniaschizophreniaACTRN12621001649808Monash University46